Cargando…
Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256546/ https://www.ncbi.nlm.nih.gov/pubmed/28115013 http://dx.doi.org/10.1186/s13075-017-1221-4 |
| _version_ | 1782498724552900608 |
|---|---|
| author | Sellam, Jérémie Rivière, Elodie Courties, Alice Rouzaire, Paul-Olivier Tolusso, Barbara Vital, Edward M. Emery, Paul Ferracioli, Gianfranco Soubrier, Martin Ly, Bineta Chavez, Houria Hendel Taoufik, Yassine Dougados, Maxime Mariette, Xavier |
| author_facet | Sellam, Jérémie Rivière, Elodie Courties, Alice Rouzaire, Paul-Olivier Tolusso, Barbara Vital, Edward M. Emery, Paul Ferracioli, Gianfranco Soubrier, Martin Ly, Bineta Chavez, Houria Hendel Taoufik, Yassine Dougados, Maxime Mariette, Xavier |
| author_sort | Sellam, Jérémie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5256546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52565462017-01-26 Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis Sellam, Jérémie Rivière, Elodie Courties, Alice Rouzaire, Paul-Olivier Tolusso, Barbara Vital, Edward M. Emery, Paul Ferracioli, Gianfranco Soubrier, Martin Ly, Bineta Chavez, Houria Hendel Taoufik, Yassine Dougados, Maxime Mariette, Xavier Arthritis Res Ther Erratum BioMed Central 2017-01-23 2017 /pmc/articles/PMC5256546/ /pubmed/28115013 http://dx.doi.org/10.1186/s13075-017-1221-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Sellam, Jérémie Rivière, Elodie Courties, Alice Rouzaire, Paul-Olivier Tolusso, Barbara Vital, Edward M. Emery, Paul Ferracioli, Gianfranco Soubrier, Martin Ly, Bineta Chavez, Houria Hendel Taoufik, Yassine Dougados, Maxime Mariette, Xavier Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title | Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title_full | Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title_fullStr | Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title_full_unstemmed | Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title_short | Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| title_sort | erratum to: serum il-33, a new marker predicting response to rituximab in rheumatoid arthritis |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256546/ https://www.ncbi.nlm.nih.gov/pubmed/28115013 http://dx.doi.org/10.1186/s13075-017-1221-4 |
| work_keys_str_mv | AT sellamjeremie erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT riviereelodie erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT courtiesalice erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT rouzairepaulolivier erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT tolussobarbara erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT vitaledwardm erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT emerypaul erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT ferracioligianfranco erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT soubriermartin erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT lybineta erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT chavezhouriahendel erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT taoufikyassine erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT dougadosmaxime erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis AT mariettexavier erratumtoserumil33anewmarkerpredictingresponsetorituximabinrheumatoidarthritis |